Authors:
CRISMON ML
FANKHAUSER MP
HINKLE GH
JANN MW
JUNI H
LOVE RC
RAY MD
STIMMEL GL
WELLS BG
Citation: Ml. Crismon et al., PSYCHIATRIC PHARMACY PRACTICE SPECIALTY CERTIFICATION PROCESS, American journal of health-system pharmacy, 55(15), 1998, pp. 1594-1598
Authors:
CHANG WH
LIN SK
LANE HY
WEI FC
HU WH
LAM YWF
JANN MW
Citation: Wh. Chang et al., REVERSIBLE METABOLISM OF CLOZAPINE AND CLOZAPINE N-OXIDE IN SCHIZOPHRENIC-PATIENTS, Progress in neuro-psychopharmacology & biological psychiatry, 22(5), 1998, pp. 723-739
Authors:
COLD JA
ZUMBRUNNEN TL
SIMPSON MA
AUGUSTIN BG
AWAD E
JANN MW
Citation: Ja. Cold et al., INCREASED LITHIUM SERUM AND RED-BLOOD-CELL CONCENTRATIONS DURING KETOROLAC COADMINISTRATION, Journal of clinical psychopharmacology, 18(1), 1998, pp. 33-37
Citation: Hy. Lane et al., ELEVATED PLASMA CLOZAPINE CONCENTRATIONS AFTER PHENOBARBITAL DISCONTINUATION, The Journal of clinical psychiatry, 59(3), 1998, pp. 131-133
Authors:
JANN MW
LIU HC
WEI FC
LIN SK
LIN SK
HU WH
CHANG WH
Citation: Mw. Jann et al., GENDER DIFFERENCES IN PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN SCHIZOPHRENIC-PATIENTS, Human psychopharmacology, 12(5), 1997, pp. 489-495
Citation: Mw. Jann et al., PLASMA ALPHA-ONE ACID GLYCOPROTEIN AND HALOPERIDOL CONCENTRATIONS IN SCHIZOPHRENIC-PATIENTS, Neuropsychobiology, 36(1), 1997, pp. 32-36
Authors:
LANE HY
LIN HN
HU OYP
CHEN CC
JANN MW
CHANG WH
Citation: Hy. Lane et al., BLOOD-LEVELS OF REDUCED HALOPERIDOL VERSUS CLINICAL EFFICACY AND EXTRAPYRAMIDAL SIDE-EFFECTS OF HALOPERIDOL, Progress in neuro-psychopharmacology & biological psychiatry, 21(2), 1997, pp. 299-311
Authors:
LANE HY
HU OYP
JANN MW
DENG HC
LIN HN
CHANG WH
Citation: Hy. Lane et al., DEXTROMETHORPHAN PHENOTYPING AND HALOPERIDOL DISPOSITION IN SCHIZOPHRENIC-PATIENTS, Psychiatry research, 69(2-3), 1997, pp. 105-111
Authors:
AUGUSTIN BG
THURSTON A
THOMAS G
HUI J
JANN MW
Citation: Bg. Augustin et al., IN-VITRO METABOLISM OF CLOZAPINE IN HUMAN HEPATIC MICROSOMES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 55-55
Citation: Sk. Lin et al., DISPOSITION OF REMOXIPRIDE IN CHINESE SCHIZOPHRENIC-PATIENTS, International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 17-20
Authors:
CHANG WH
JANN MW
CHIANG TS
LIN HN
HU WH
CHIEN CP
Citation: Wh. Chang et al., PLASMA HALOPERIDOL AND REDUCED HALOPERIDOL CONCENTRATIONS IN A GERIATRIC POPULATION, Neuropsychobiology, 33(1), 1996, pp. 12-16
Citation: Mw. Jann et al., HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-CONCENTRATIONS AFTER A LOADING DOSE REGIMEN WITH HALOPERIDOL DECANOATE, Progress in neuro-psychopharmacology & biological psychiatry, 20(1), 1996, pp. 73-86
Authors:
LIU HC
CHANG WH
WEI FC
LIN SK
LIN SK
JANN MW
Citation: Hc. Liu et al., MONITORING OF PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN REFRACTORY SCHIZOPHRENIC-PATIENTS, Therapeutic drug monitoring, 18(2), 1996, pp. 200-207
Citation: Fc. Wei et al., A PRACTICAL LOADING DOSE METHOD FOR CONVERTING SCHIZOPHRENIC-PATIENTSFROM ORAL TO DEPOT HALOPERIDOL THERAPY, The Journal of clinical psychiatry, 57(7), 1996, pp. 298-302
Authors:
HUANG HF
JANN MW
WEI FC
CHANG TP
CHEN JS
JUANG DJ
LIN SK
LAM YWF
CHIEN CP
CHANG WH
Citation: Hf. Huang et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN BUSPIRONE AND HALOPERIDOLIN PATIENTS WITH SCHIZOPHRENIA, Journal of clinical pharmacology, 36(10), 1996, pp. 963-969